Maternal hepatitis B e antigen can be an indicator for antiviral prophylaxis of perinatal transmission of hepatitis B virus

References

• Global hepatitis report, 2017. Geneva: World Health Organization; 2017.
   Google Scholar
• Global health sector strategy on viral hepatitis 2016-2021. Geneva: World Health Organization. 2016.
   Google Scholar
• Cooke G, Andrieux-Meyer I, Applegate T, et al. Accelerating the elimination of viral hepatitis: a Lancet gastroenterology & Hepatology commission. Lancet Gastroenterol Hepatol. 2019;4:135–184.
   PubMed Web of Science ®Google Scholar
• Pan CQ, Duan Z, Dai E, et al. Tenofovir to prevent hepatitis B transmission in mothers with high viral load. New Engl J Med. 2016 Jun 16;374(24):2324–2334.
   PubMed Web of Science ®Google Scholar
• Jourdain G, Ngo-Giang-Huong N, Harrison L, et al. Tenofovir versus placebo to prevent perinatal transmission of hepatitis B. New Engl J Med. 2018 Mar 8;378(10):911–923.
   PubMed Web of Science ®Google Scholar
• Guidelines for the prevention, care and treatment of persons with chronic hepatitis B infection. Geneva: World Health Organization; 2015.
   Google Scholar
• Peng S, Wan Z, Liu T, et al. Incidence and risk factors of intrauterine transmission among pregnant women with chronic hepatitis B virus infection. J Clin Gastroenterol. 2019 Jan;53(1):51–57.
   Web of Science ®Google Scholar
• Lu Y, Zhu FC, Liu JX, et al. The maternal viral threshold for antiviral prophylaxis of perinatal hepatitis B virus transmission in settings with limited resources: A large prospective cohort study in China. Vaccine. 2017 Dec 4;35(48 Pt B):6627–6633.
   PubMed Web of Science ®Google Scholar
• Kubo A, Shlager L, Marks AR, et al. Prevention of vertical transmission of hepatitis B: an observational study. Ann Intern Med. 2014 Jun 17;160(12):828–835.
   PubMed Web of Science ®Google Scholar
• Wen WH, Chang MH, Zhao LL, et al. Mother-to-infant transmission of hepatitis B virus infection: significance of maternal viral load and strategies for intervention. J Hepatol. 2013 Jul;59(1):24–30.
   PubMed Web of Science ®Google Scholar
• Yin X, Han G, Zhang H, et al. A real-world prospective study of mother-to-child transmission of HBV in China using a mobile health application (Shield 01). J Clin Transl Hepatol. 2020 Mar 28;8(1):1–8.
   Web of Science ®Google Scholar
• Wen WH, Huang CW, Chie WC, et al. Quantitative maternal hepatitis B surface antigen predicts maternally transmitted hepatitis B virus infection. Hepatology. 2016 Nov;64(5):1451–1461.
   PubMed Web of Science ®Google Scholar
• Sun KX, Li J, Zhu FC, et al. A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women. Vaccine. 2012 Aug 3;30(36):5335–5340.
   PubMed Web of Science ®Google Scholar
• Peng S, Wan Z, Liu T, et al. Quantitative hepatitis B surface antigen predicts hepatitis B transmission in infants born to e antigen-positive mothers. J Clin Gastroenterol. 2020 Jan;54(1):76–82.
   PubMed Web of Science ®Google Scholar
• Terrault NA, Bzowej NH, Chang KM, et al. AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2016 Jan;63(1):261–283.
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the Liver. EASL 2017 clinical practice guidelines on the management of hepatitis B virus infection. J Hepatol. 2017 Aug;67(2):370–398.
   PubMed Web of Science ®Google Scholar
• Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology. 2010 Jun;51(6):1933–1944.
   PubMed Web of Science ®Google Scholar
• Shimakawa Y, Njie R, Ndow G, et al. Development of a simple score based on HBeAg and ALT for selecting patients for HBV treatment in Africa. J Hepatol. 2018 Oct;69(4):776–784.
   Web of Science ®Google Scholar
• Segeral O, N'Diaye DS, Prak S, et al. Usefulness of a serial algorithm of HBsAg and HBeAg rapid diagnosis tests to detect pregnant women at risk of HBV mother-to-child transmission in Cambodia, the ANRS 12328 pilot study. J Clin Virol. 2018 Dec;109:29–34.
   PubMed Web of Science ®Google Scholar
• Boucheron P, Lu Y, Yoshida K, et al. Accuracy of HBeAg to identify pregnant women at risk of transmitting hepatitis B virus to their neonates: a systematic review and meta-analysis. Lancet Infect Dis. 2021 Jan;21(1):85–96.
   PubMed Web of Science ®Google Scholar
• Prevention of mother-to-child transmission of hepatitis B virus: guidelines on antiviral prophylaxis in pregnancy. Geneva: World Health Organization; 2020.
   Google Scholar
• Xiao Y, Sun K, Duan Z, et al. Quasispecies characteristic in “a” determinant region is a potential predictor for the risk of immunoprophylaxis failure of mother-to-child-transmission of sub-genotype C2 hepatitis B virus: a prospective nested case-control study. Gut. 2020 May;69(5):933–941.
   PubMed Web of Science ®Google Scholar
• Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016 Jan;10(1):1–98.
   PubMed Web of Science ®Google Scholar
• Visvanathan K, Dusheiko G, Giles M, et al. Managing HBV in pregnancy. prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders. Gut. 2016 Feb;65(2):340–350.
   PubMed Web of Science ®Google Scholar
• Chinese Society of Hepatology CMA, Chinese Society of Infectious Diseases. The guideline of prevention and treatment for chronic hepatitis B: a 2019 update. Chinese Journal of Hepatology. 2019;11(4):5–27.
   Google Scholar
• Pan CQ, Duan ZP, Bhamidimarri KR, et al. An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus. Clin Gastroenterol Hepatol. 2012 May;10(5):452–459.
   PubMed Web of Science ®Google Scholar
• Chen HL, Lin LH, Hu FC, et al. Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV. Gastroenterology. 2012 Apr;142(4):773–781.e2.
   PubMed Web of Science ®Google Scholar
• Chang CY, Aziz N, Poongkunran M, et al. Serum aminotransferase flares in pregnant and postpartum women with current or prior treatment for chronic hepatitis B. J Clin Gastroenterol. 2018 Mar;52(3):255–261.
   Web of Science ®Google Scholar
• Nguyen V, Tan PK, Greenup AJ, et al. Anti-viral therapy for prevention of perinatal HBV transmission: extending therapy beyond birth does not protect against post-partum flare. Aliment Pharmacol Ther. 2014 May;39(10):1225–1234.
   PubMed Web of Science ®Google Scholar
• Tseng TC, Kao JH. Treating immune-tolerant hepatitis B. J Viral Hepat. 2015 Feb;22(2):77–84.
   PubMed Web of Science ®Google Scholar